Early Symptoms of Vitiligo and How It Is Treated

The main goal of vitiligo treatment is to recover at least part of the lost skin color. The degree and speed of pigment return vary by individual, but improvement is generally slow and gradual.

For example, when phototherapy or ointment treatment continues for several months or more, pigment cells regenerate within the white patches in the form of brown speckles that spread outward, and skin color begins to return. It is difficult, however, for the original color to be fully restored at once; partial repigmentation usually takes place gradually. Pigment gained through treatment can also fade again over time, so maintenance treatment is sometimes needed to keep the results. Rather than the idea of a complete cure, it is realistic to focus on regaining as much skin color as possible through ongoing care and preventing further worsening.

The speed and pattern of vitiligo's progression differ from person to person and are hard to predict. It generally tends to advance slowly, but at times it can spread rapidly. For active vitiligo with frequent new patches, treatments such as a short course of oral corticosteroids (e.g., prednisone) can be tried to slow the progression. Meanwhile, segmental vitiligo, confined to one side of the body, usually begins at a young age, progresses quickly for about 6–12 months, and then generally stops. Non-segmental vitiligo (the common form appearing across the body) has no definite point at which progression fully stops, but treatment can suppress the expansion of patches or slow it down.

No. Vitiligo is not a contagious disease. It is not caused by bacterial or viral infection, and it cannot be passed on through contact with a patient. As a non-infectious skin condition arising from an autoimmune abnormality, skin contact or sharing daily life with someone who has vitiligo carries no risk of transmission whatsoever, so you can be at ease.

Daily care and lifestyle habits also matter in vitiligo. Following the skin care and lifestyle guidelines below helps prevent vitiligo from worsening and keeps the skin healthy.

Vitiligo is a condition that can occur in anyone, regardless of age or ethnicity. It appears in roughly 0.5–2% of the world's population, at nearly similar rates regardless of skin color or ethnicity. How noticeable it is, however, can vary with skin color. In people with darker skin or those who tan easily, the color contrast between the white vitiligo patches and the surrounding normal skin is stark, making them stand out more. In people with very fair skin, the white patches may be relatively hard to notice. In terms of age, onset at a young age is common: about 50% of all vitiligo patients experience their first symptoms before age 20, and cases beginning in childhood are frequent.

Segmental vitiligo, confined to one area, is reported relatively often in young children and adolescents; as described above, this form tends to progress briefly in the early phase and then stop. In adults, the non-segmental form, with patches appearing across the body, is more common — but ultimately the underlying pathology of vitiligo does not differ greatly by age.

Vitiligo is a classic autoimmune disease. That is, it develops when an abnormal immune response causes the body to recognize part of itself as an enemy and attack it. For this reason, vitiligo patients often have other accompanying autoimmune diseases or family members with them. The link with autoimmune thyroid disease (such as Hashimoto's thyroiditis and Graves' disease) is especially strong: about 20% of vitiligo patients are reported to also have thyroid disease.

It also tends to co-occur with autoimmune conditions such as alopecia areata, type 1 diabetes, pernicious anemia, psoriasis, rheumatoid arthritis, and lupus. Overlapping genetic predispositions are common, so certain immune-related genes are found in vitiligo patients, and multiple autoimmune diseases sometimes appear within one family. Patients diagnosed with vitiligo are therefore advised to check periodically for other autoimmune diseases (e.g., thyroid function tests).